Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation

Objectif

Electrical brain stimulation has been successfully used since the 1990s to treat neurological illnesses, particularly movement disorders.
Most of the devices for this novel approach are based on the old pacemaker technology. Companies are unwilling to take device development risks & rely on established tech, limiting new therapy developments. Many neurological diseases are still treated with pharmaceuticals only, which has limited effectiveness and causes severe side effects. Neuromodulation—electrical stimulation research has increased in recent decades. Additional recording capabilities & closed loop therapy expand therapeutic options.
CorTec aims to provide novel implantable tech to overcome the current limitations: it enables researchers, medical institutions & industry to develop new therapies & devices. We plan to finalise the development of our tech for stroke rehabilitation, conduct clinical trials & get market approval in 2029, generating €250M in sales in 2030.

Champ scientifique (EuroSciVoc)

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) HORIZON-EIC-2022-ACCELERATOR-01

Voir tous les projets financés au titre de cet appel

Coordinateur

CORTEC GMBH
Contribution nette de l'UE
€ 2 500 000,00
Adresse
NEUER MESSPLATZ 3
79108 Freiburg Im Breisgau
Allemagne
PME
Oui
Région
Baden-Württemberg Freiburg Freiburg im Breisgau, Stadtkreis
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Liens
Coût total
€ 3 675 427,50